«

»

Apr 10

Results of the MSC–HF trial, recently presented at the American College of Cardiology 2014 Scientific Sessions

Results of the MSC–HF trial, recently presented at the American College of Cardiology 2014 Scientific Sessions, have revealed that patients receiving intramyocardial injections of autologous mesenchymal stromal cells (MSC) for their ischemic heart disease reported increases in functional heart muscle, LV end–systolic volumes, stroke volume, and LVEF, compared with control patients who had received similar intramyocardial injections of saline. However, these gains did not translate into clinical benefit as measured by NYHA class and six–minute–walk distance.

Leave a Reply

Your email address will not be published. Required fields are marked *

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>